G. Fontanella, Manganiello Cat, S. Borrelli, S. Natalizi, B. Brogna, Catarinella, A. Deblasio
{"title":"Metastatic mixed gestational trophoblastic tumour of the uterus: A case report","authors":"G. Fontanella, Manganiello Cat, S. Borrelli, S. Natalizi, B. Brogna, Catarinella, A. Deblasio","doi":"10.15761/ogr.1000156","DOIUrl":"https://doi.org/10.15761/ogr.1000156","url":null,"abstract":"A 34 year-old Caucasian woman was referred to our Obs/Gyn division, presenting with unexplained metrorrhagia, almost 4 months after normal childbirth. All laboratory tests were unremarkable, except for elevated serum β-HCG (4333 IU/L) and CA-125 levels (366 KU/L). The patient was then referred to our Radiology unit, for a Chest X-ray and abdominal ultrasound evaluation; a dishomogeneously hypoecoic uterine mass (4.4x4.2 cm, Figure 1) was noted. Except for this finding, the initial imaging tests were otherwise unremarakable. The patient was immediately scheduled for a contrast-enhanced Pelvic MRI evaluation, that confirmed the presence of a dishomogenous, irregularly round mass (4.5x4.3x3.6 cm, Figures 2-5), in the endometrial cavity but protruding outwards, eroding the myometrium, the latter barely recognisable at the right lateral aspect of the uterine fundus. The postcontrast acquisitions showed the mass to be highly vascular, almost reaching the outlying sierosa. Figure 1. Ultrasound appearance of the mixed PSTT/Choriocarcinoma GTN. A rounded, heterogeneously ecoic mass is noted within the endometrial cavity","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"9 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87316174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Post-partum acute renal failure: A case report","authors":"Diana Padovani, M. Angelini, L. Driul","doi":"10.15761/ogr.1000153","DOIUrl":"https://doi.org/10.15761/ogr.1000153","url":null,"abstract":"Background: Acute renal failure associated to renal cortical necrosis is a rare condition that can appear in pregnancy, during or after the delivery. It can be caused by various factors which must all be excluded in order to reach the correct diagnosis. Due to its low incidence in developed country, it presents a challenging diagnosis, cause management and treatment. Case report: Here we report a rare case of acute renal failure with renal cortical necrosis probably caused by post-partum hemorrhage. A 36-years-old primiparous woman, after a post-partum hemorrhage, presented low platelets count, anuria and increase serum creatinine level that necessitate daily dialysis and Continuous Veno-Venous Hemofiltration. After the discharge she presented persisting stage IV chronic renal insufficiency, currently being treated. After excluding all possible causes of pregnancy-related acute renal failure, the only reasonable explanation was renal cortical necrosis due to post-partum hemorrhage. Conclusion: Due to a loss of 3000 cc of blood, the patient suffered of a life threating disease. The acute renal failure is a serious condition that must be taken into consideration in case of post-partum bleeding and promptly.","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"1 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89764420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An exploratory, prospective cohort study of non-invasive dynamic quadripolar radiofrequency energy in vulvar lichen management. The new-generation DQRF™ option","authors":"V. Prestia, Elena G. Bertozzi, M. Raichi","doi":"10.15761/ogr.1000158","DOIUrl":"https://doi.org/10.15761/ogr.1000158","url":null,"abstract":"Introduction: The main vulvar lichen treatment goal is itch reduction; improving and preserving the skin integrity and texture, healing the fissures and erosions, and preventing the later disfiguring fibrosis are the other crucial treatment goals. The side effect burden of high-potency topical corticosteroids, the current gold standard, can be heavy and alternative options are welcome. The paper illustrates the first exploratory outcomes in vulvar lichen planus and lichen sclerosus by the latest low- energy technological evolution of radiofrequency treatments, Dynamic Quadripolar RadioFrequency™, in synergistic combination with in-depth penetration of active principles via Ultra-Pulsed Radioporation™. Methods: Explorative cohort study in 58 ambulatory women 27 to 80 years old, eighteen nulliparous and 26 uniparous, 53.4% in the postmenopausal period. The DQRF™ treatment program mainly aimed at symptom control, with four weekly sessions - 10 minutes over the lichenified vulvar areas and 10 minutes of vaginal rejuvenation even without evidence of lichen vaginal extension. Assessments (baseline and at the end of the treatment cycle): pain and dyspareunia (10-cm impromptu Visual Analogue Scales), vulvar burning (4-score Likert-like impromptu scale), vulvar lesions (binary evaluation - Yes / No). Results: After a month, vulvar lichen inflammation appeared cooled down, and all cohort women reported dramatic improvements in daily and sexual symptoms - variable between -81.2% and -92% for pain, burning and itching, and -83% for dyspareunia. Conclusions: Control of lichen inflammation, as documented by sequential photographs, is likely the rationale behind the very favourable outcomes after DQRF™ + UPR™ treatment. Well-designed comparative studies are critical to defining the role of the novel radiofrequency technology in vulvar lichen management.","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"25 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87406504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Firas Al-Rshoud, Azmi Qudsi, Firas Wael Naffa, Bayan Al Omari, Areen Ghazi AlFalah
{"title":"The Use and Efficacy of Mobile Fertility-tracking Applications as a Method of Contraception: a Survey.","authors":"Firas Al-Rshoud, Azmi Qudsi, Firas Wael Naffa, Bayan Al Omari, Areen Ghazi AlFalah","doi":"10.1007/s13669-021-00305-4","DOIUrl":"https://doi.org/10.1007/s13669-021-00305-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to investigate the use and efficacy of fertility tracking applications as a natural contraceptive method since there has been a worldwide increase in the development and use of applications that monitor the menstrual cycle and fertility window. An anonymous online survey had been conducted in order to achieve this goal, and a total of 375 married women from Jordan responded to our survey.</p><p><strong>Recent findings: </strong>Topics discussed include fertility awareness-based methods (FAM) of contraception in which mobile applications fall into, and their efficacy and failure rates, comparing them with other methods of contraception while taking into account the typical and perfect use of each method. Motivation has also been looked at as a factor affecting the efficacy of FAM and advantages/disadvantages of this method were discussed. The prevalence of mobile applications that monitor fertility signs and their expected increased use over the next years was also discussed.</p><p><strong>Summary: </strong>The use of fertility tracking applications is not uncommon amongst sexually active women in reproductive age, and the majority of users rely on them to track their fertility window. However, the efficacy of such applications as a method of contraception is not high and there is a significant failure rate especially if used alone. It is worth noting that 50% of women who reported failure relied solely on mobile applications and fertility window assessment without using other methods of contraception, and thus we advise women to use more reliable methods of contraception and not rely solely on such applications.</p>","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"10 2","pages":"25-29"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13669-021-00305-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25558624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B. Eiben, H. Borth, N. Kutur, C. Courtis, Anna Teubert, S. Knippenberg, Thomas Winkler, R. Glaubitz
{"title":"Clinical experience with noninvasive prenatal testing in Germany: Analysis of over 500 high-risk cases for trisomy 21, 18, 13 and monosomy X","authors":"B. Eiben, H. Borth, N. Kutur, C. Courtis, Anna Teubert, S. Knippenberg, Thomas Winkler, R. Glaubitz","doi":"10.15761/ogr.1000157","DOIUrl":"https://doi.org/10.15761/ogr.1000157","url":null,"abstract":"Analysis of 545 NIPT high-risk cases with high risk for trisomy 21 (T21), 18 (T18), and 13 (T13), as well as monosomy X (MX) from routine NIPT testing in a single prenatal center in Germany. Analysis was performed using the VeriSeq NIPT Solution v2 (Illumina Inc., USA). The assessment of true vs false positive results were based on clinical outcome data. The average fetal fraction of 9.7% was within the expected range in T21 and MX but lower in T18 and T13. For all high-risk groups sensitivity and specificity was far above 99%. The positive predictive value (PPV) was highest at trisomy 21 with 94.1%, followed by trisomy 18 with 80.9%. For trisomy 13 and Monosomy X, the PPV was clearly lower at 60.5% and 65.6%, respectively. PPV was dependent on different indications and maternal age. We could show that statistical tools of the method like the log likelihood ratio (LLR) score and T-Statistics value are important to distinguish between (clinical) false positive and true positive NIPT results in trisomies. The relationship between results and quality scores is less significant for MX cases. The study shows that the Illumina VeriSeq v2 procedure is a highly reliable NIPT method with a low no call rate in the hands of experienced diagnostic laboratories.","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"09 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86036268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Challenges in managing a pregnancy with underlying renal fibromuscular dysplasia","authors":"Kumaressan Ragunathan, Selva Ashwini Selvaraj","doi":"10.15761/ogr.1000159","DOIUrl":"https://doi.org/10.15761/ogr.1000159","url":null,"abstract":"","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"33 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86062515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Monteith, Eva Forman, A. Kampmeijer, S. Jaleel, B. Hayes, K. Flood
{"title":"The natural history of moderate-severe ventriculomegaly: A review of cases managed expectantly in an Irish tertiary Centre","authors":"C. Monteith, Eva Forman, A. Kampmeijer, S. Jaleel, B. Hayes, K. Flood","doi":"10.15761/ogr.1000154","DOIUrl":"https://doi.org/10.15761/ogr.1000154","url":null,"abstract":"Introduction: Prenatal counselling for cerebral ventriculomegaly is challenging due to varied factors and prognoses. There is limited data about the natural history of affected pregnancies managed expectantly. We sought to review the prenatal course, obstetric and paediatric outcomes in cases of moderate to severe cerebral ventriculomegaly in an Irish tertiary maternity unit. Materials and methods: Retrospective review of patients attending the Fetal Assessment Unit from 2006-2014 with lateral cerebral ventricular measurements >12 mm on ultrasound. Results: During the nine-year period, 93 cases were identified with pregnancy outcome data available for 80 cases and 54 continuing in our institution. Vaginal delivery was achieved in 28.9% of women with 71.1% undergoing caesarean. There were 9 cases of intrauterine demise and an additional six neonatal deaths and three paediatric deaths. An isolated neural tube defect was present in 12 babies. Of the remaining 33 babies a diagnosis was confirmed in 60.6% of which, 45% were achieved antenatally. Conclusions: A diagnosis was obtained in 70% of live births. The presence of ventriculomegaly had a significant impact on the mode of delivery and maternal morbidity. The survival rate was 66.6% with high rate of neurodevelopmental delay recognized in survivors particularly in cases without a clear diagnosis.","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"4 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75338414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Correction to: Pharmacokinetics of Hormonal Contraception in Individuals with Obesity: a Review","authors":"Shaalini Ramanadhan, W. Jusko, A. Edelman","doi":"10.1007/s13669-020-00301-0","DOIUrl":"https://doi.org/10.1007/s13669-020-00301-0","url":null,"abstract":"","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"10 1","pages":"14-15"},"PeriodicalIF":0.5,"publicationDate":"2020-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13669-020-00301-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43280511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Medical transition for gender diverse patients.","authors":"Chelsea N Fortin, Molly B Moravek","doi":"10.1007/s13669-020-00297-7","DOIUrl":"https://doi.org/10.1007/s13669-020-00297-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to provide an up-to-date overview of gender-affirming hormone therapy, including the various hormone regimens available, the efficacy and potential risks of these treatments, and considerations for surveillance and long-term care.</p><p><strong>Recent findings: </strong>Recent studies reaffirm that hormone therapy has positive physical and psychological effects for many transgender individuals. The overall risks of treatment are low. Transgender women may have an increased risk of venous thromboembolism and breast cancer based on recent cohort studies, but these findings have yet to be confirmed with randomized controlled trials. Important long-term considerations include metabolic, cardiovascular, and skeletal health.</p><p><strong>Summary: </strong>High-quality, long-term studies on the effectiveness and safety of various gender-affirming hormone treatment regimens are lacking, but the currently available evidence suggests that it is overall safe and effective with appropriate oversight.</p>","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"9 4","pages":"166-177"},"PeriodicalIF":0.5,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13669-020-00297-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9157964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}